## Long -term growth of tumor-infiltrating lymphocytes (TIL) in high concentrations of rlL-2 is required for generation of therapeutic numbers of cells for adoptive immunotherapy of human cancer. Under these conditions rlL-2 promotes both anti-tumor cytotoxicity and lymphocyte growth from tumors of
Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes
β Scribed by Cornelis J. A. Punt; Jose A. M. Barbuto; Hua Zhang; William J. Grimes; Kenneth D. Hatch; Evan M. Hersh
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 905 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Heteroconjugate (HC) antibody has a potential use in cancer biotherapy because of its ability to mimic antigenic specificity and induce cytotoxicity in the activated lymphocytes against various tumor cells. This study investigated the effects of HC antibody (antiβCD3 MAb x antiβp97 mela
Mononuclear cell infiltration is frequently seen within human solid tumors. Effector cells within the tumor site usually fail to exhibit cytotoxic or natural killer activity when freshly isolated; however, they develop potent and sometimes specific cytotoxicity after expansion in ILL Thus, local tum
Melanoma and renal-cell carcinoma (RCC) are generally consided to be relatively immunogenic tumor types in humans. In the case of melanoma, many major histocompatibility complex (MHC) class I-restricted tumor-specific cytotoxic T lymphocytes (Cn) have been isolated from either tumorinfiltrating lymp
The author wishes to acknowledge the excellent technical assistance of Mrs. Melinda Donnelly and Mrs. Ruthann Mullen and to thank F'rofessor William A. Tisdale for support and encouragement.